Literature DB >> 9289856

[An interdisciplinary consensus conference on the diagnosis and therapy of testicular tumors].

M Bamberg1, H J Schmoll, L Weissbach, J Beyer, C Bokemeyer, A Harstrick, W Höltl, R Souchon, H Vogler.   

Abstract

In 1988 the German testicular working group was set up by leading experts in the fields of urology, medical and radio-oncology. Since then, the working group has initiated several clinical studies and conferences with the aim of defining current standards in the treatment of testicular germ cell tumours. After a series of preliminary joint meetings with representatives from the AUO, AIO and ARO of the "Deutsche Krebsgesellschaft", a conference was held in May 1996 to agree on a consensus in diagnosis and treatment of testicular germ cell tumours. The standards which have been agreed on at the conference refer to the current international literature and provide recommendations for the majority of clinical situations. Treatment strategies differing from these standards should not be chosen except for well argued individual settings or patients treated in clinical trials. No consensus could be reached for nonseminomatous stage I, IIA and IIB tumours. As a consequence, the differing treatment strategies for these stages are summarized in this paper. A subsequent conference in later years is needed to possibly find an agreement for these tumour stages and to update the current standards according to new clinical experience and knowledge.

Entities:  

Mesh:

Year:  1997        PMID: 9289856     DOI: 10.1007/bf03038315

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  24 in total

1.  Risk-adapted treatment choice in stage I nonseminomatous testicular germ cell cancer by regarding vascular invasion in the primary tumor: a prospective trial.

Authors:  J Pont; W Höltl; D Kosak; E Machacek; H Kienzer; H Julcher; N Honetz
Journal:  J Clin Oncol       Date:  1990-01       Impact factor: 44.544

Review 2.  [Stage-oriented therapy in nonseminomatous testicular tumors].

Authors:  H G Derigs; C Huber; H J Schmoll
Journal:  Dtsch Med Wochenschr       Date:  1994-02-04       Impact factor: 0.628

Review 3.  [Tumor markers in testicular cancer].

Authors:  K Mann
Journal:  Urologe A       Date:  1990-03       Impact factor: 0.639

4.  Early clinical stages of nonseminomatous testis cancer. Evaluation of the primary treatment and follow-up procedures of the SWENOTECA project.

Authors:  O Klepp; A M Olsson; S Ous; S Nilsson; P A Høisaether; K Tveter
Journal:  Scand J Urol Nephrol       Date:  1991

5.  Prognostic factors for favorable outcome in disseminated germ cell tumors.

Authors:  R Birch; S Williams; A Cone; L Einhorn; P Roark; S Turner; F A Greco
Journal:  J Clin Oncol       Date:  1986-03       Impact factor: 44.544

Review 6.  Stage I nonseminomatous germ-cell testicular cancer--management options and risk-benefit considerations.

Authors:  J P Donohue; J A Thornhill; R S Foster; R G Rowland; R Bihrle
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

7.  High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group.

Authors:  W Siegert; J Beyer; I Strohscheer; H Baurmann; H Oettle; J Zingsem; R Zimmermann; C Bokemeyer; H J Schmoll; D Huhn
Journal:  J Clin Oncol       Date:  1994-06       Impact factor: 44.544

8.  Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups.

Authors:  E W Steyerberg; H J Keizer; S D Fosså; D T Sleijfer; G C Toner; H Schraffordt Koops; P F Mulders; J E Messemer; K Ney; J P Donohue
Journal:  J Clin Oncol       Date:  1995-05       Impact factor: 44.544

9.  Management of contralateral testicular intraepithelial neoplasia in patients with testicular germ-cell tumor.

Authors:  K P Dieckmann; V Loy
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

10.  Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide.

Authors:  S D Williams; R Birch; L H Einhorn; L Irwin; F A Greco; P J Loehrer
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

View more
  3 in total

Review 1.  [Testicular intraepithelial neoplasms (TIN). An indication for radiotherapy?].

Authors:  J Classen; K P Dieckmann; V Loy; M Bamberg
Journal:  Strahlenther Onkol       Date:  1998-04       Impact factor: 3.621

2.  [Value of radiotherapy of residual tumors after chemotherapy of metastatic seminomas].

Authors:  M Bamberg; J Classen
Journal:  Strahlenther Onkol       Date:  1998-08       Impact factor: 3.621

3.  Radiotherapy with 16 Gy may fail to eradicate testicular intraepithelial neoplasia: preliminary communication of a dose-reduction trial of the German Testicular Cancer Study Group.

Authors:  J Classen; K Dieckmann; M Bamberg; R Souchon; S Kliesch; M Kuehn; V Loy
Journal:  Br J Cancer       Date:  2003-03-24       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.